Share chart Metagenomi, Inc.
Extended chart
Simple chart
About Metagenomi, Inc.
Metagenomi, Inc., биотехнологическая компания по редактированию генов, разрабатывает терапевтические препараты для пациентов с использованием набора инструментов редактирования генома, основанного на метагеномике, в Соединенных Штатах. Инструментарий компании для редактирования генома включает в себя программируемые нуклеазы, редакторы оснований, а также системы интеграции, опосредованные РНК и ДНК, такие как системы первичного редактирования и кластеризованные с регулярными промежутками короткие палиндромные транспозазы, связанные с повторами. more details| IPO date | 2024-02-09 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.metagenomi.co |
| Цена ао | 1.91 |
| Change price per day: | 0% (1.94) |
|---|---|
| Change price per week: | -5.37% (2.05) |
| Change price per month: | -20.82% (2.45) |
| Change price per 3 month: | -37.52% (3.105) |
| Change price per half year: | -29.45% (2.75) |
| Change price per year: | -82.4% (11.02) |
| Change price per 3 year: | 0% (1.94) |
| Change price per 5 year: | 0% (1.94) |
| Change price per 10 year: | 0% (1.94) |
| Change price per year to date: | -51.62% (4.01) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| SPDR S&P International Small Cap ETF | 0.01013 | 8.94 | 3.10348 |
| Schwab International Small-Cap Equity ETF | 0.00663 | 10.07 | 3.20638 |
| iShares Micro-Cap ETF | 0.00387 | 17.09 | 1.54048 |
| Dimensional International Small Cap Value ETF | 0.00118 | 7.13 | 4.55441 |
| Dimensional International Core Equity 2 ETF | 0.00113 | 6.52 | 3.69996 |
| Avantis International Equity ETF | 0.00075 | 6.46 | 3.80856 |
| Dimensional International Small Cap ETF | 0.00071 | 5.69 | 3.34747 |
iShares Russell 2000 Growth ETF
|
0.00069 | 38.04 | 0.6026 |
| Dimensional International Core Equity Market ETF | 0.0002 | 13.09 | 3.48343 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0 | 9.39 | 3.09932 |
| 0.00000 | 11.71 | 3.05 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Brian Charles Thomas Ph.D. | Co-Founder, CEO & Chairman of the Board | 859.34k | 1969 (56 years) |
| Dr. Jian Irish M.B.A., Ph.D. | President, COO & Director | 729.82k | 1964 (61 year) |
| Dr. Sarah B. Noonberg M.D., Ph.D. | Chief Medical Officer | 591.49k | 1968 (57 years) |
| Ms. Pamela M. Wapnick M.B.A. | Chief Financial Officer | N/A | 1966 (59 years) |
| Mr. Matthew L. Wein J.D. | Vice President of Corporate Legal, Compliance & Corporate Secretary | N/A | 1971 (54 years) |
| Dr. Alan Brooks Ph.D. | Senior Vice President of Preclinical | N/A | 1966 (59 years) |
| Dr. Christopher Brown | Head of Discovery | N/A | 1989 (36 years) |
| Mr. Simon Harnest M.Sc. | Chief Investment Officer & Senior VP of Investor Relations | N/A | 1987 (38 years) |
| Dr. Joseph Knowles M.D. | Co-Founder & Member of Scientific Advisory Board |
Address: United States, Emeryville. CA, 5959 Horton Street - open in Google maps, open in Yandex maps
Website: https://www.metagenomi.co
Website: https://www.metagenomi.co
